Abstract:Alzheimer's disease (AD), the most common type of dementia, is a severe neurodegenerative disorder. Identifying biomarkers that can track the progress of the disease has recently received increasing attentions in AD research. An accurate prediction of disease progression would facilitate optimal decision-making for clinicians and patients. A definitive diagnosis of AD requires autopsy confirmation, thus many clinical/cognitive measures including Mini Mental State Examination (MMSE) and Alzheimer's Disease Assessment Scale cognitive subscale (ADAS-Cog) have been designed to evaluate the cognitive status of the patients and used as important criteria for clinical diagnosis of probable AD. In this paper, we consider the problem of predicting disease progression measured by the cognitive scores and selecting biomarkers predictive of the progression. Specifically, we formulate the prediction problem as a multi-task regression problem by considering the prediction at each time point as a task and propose two novel multi-task learning formulations. We have performed extensive experiments using data from the Alzheimer's Disease Neuroimaging Initiative (ADNI). Specifically, we use the baseline MRI features to predict MMSE/ADAS-Cog scores in the next 4 years. Results demonstrate the effectiveness of the proposed multi-task learning formulations for disease progression in comparison with single-task learning algorithms including ridge regression and Lasso. We also perform longitudinal stability selection to identify and analyze the temporal patterns of biomarkers in disease progression. We observe that cortical thickness average of left middle temporal, cortical thickness average of left and right Entorhinal, and white matter volume of left Hippocampus play significant roles in predicting ADAS-Cog at all time points. We also observe that several MRI biomarkers provide significant information for predicting MMSE scores for the first 2 years, however very few are shown to be significant in predicting MMSE score at later stages. The lack of predictable MRI biomarkers in later stages may contribute to the lower prediction performance of MMSE than that of ADAS-Cog in our study and other related studies.

MC-RVAE: Multi-channel recurrent variational autoencoder for multimodal Alzheimer's disease progression modelling

Individualized multi-horizon MRI trajectory prediction for Alzheimer's Disease

Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network

Normative Modeling using Multimodal Variational Autoencoders to Identify Abnormal Brain Structural Patterns in Alzheimer Disease

DeepAD: A Robust Deep Learning Model of Alzheimer's Disease Progression for Real-World Clinical Applications

Multi-Channel Stochastic Variational Inference for the Joint Analysis of Heterogeneous Biomedical Data in Alzheimer's Disease

Modeling disease progression via multi-task learning

Incomplete multi-modal representation learning for Alzheimer's disease diagnosis

Uncovering Neural Substrates Across Alzheimer’s Disease Stages Using Contrastive Variational Autoencoder

Multimodal normative modeling in Alzheimer Disease with introspective variational autoencoders

Uncovering neural substrates across Alzheimer's disease stages using contrastive variational autoencoder

Multi-modal Variational Autoencoders for normative modelling across multiple imaging modalities

A deep generative multimodal imaging genomics framework for Alzheimer's disease prediction

Multimodal Alzheimer's disease classification through ensemble deep random vector functional link neural network

Prediction of Alzheimer's Progression based on Multimodal Deep-Learning-based Fusion and Visual Explainability of Time-Series Data

Training recurrent neural networks robust to incomplete data: application to Alzheimer's disease progression modeling

An interpretable generative multimodal neuroimaging-genomics framework for decoding Alzheimer's disease

Multi-modal Sequence Learning for Alzheimer's Disease Progression Prediction with Incomplete Variable-Length Longitudinal Data.

Spatio-Temporal Similarity Measure based Multi-Task Learning for Predicting Alzheimer's Disease Progression using MRI Data

Bridging Imaging and Clinical Scores in Parkinson's Progression via Multimodal Self-Supervised Deep Learning

Multi-view prediction of Alzheimer’s disease progression with end-to-end integrated framework